NCT04269356View on ClinicalTrials.gov

Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
Healthy Participants
Interventions
DRUG

BMS-986256

Specified dose on specified days

DRUG

Milk of magnesia

Specified dose on specified days

Trial Locations (1)

53704

Covance - Clinical Pharmacology Services - Madison, Madison

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY